BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35149839)

  • 61. Rac1-mediated cytoskeleton rearrangements induced by intersectin-1s deficiency promotes lung cancer cell proliferation, migration and metastasis.
    Jeganathan N; Predescu D; Zhang J; Sha F; Bardita C; Patel M; Wood S; Borgia JA; Balk RA; Predescu S
    Mol Cancer; 2016 Sep; 15(1):59. PubMed ID: 27629044
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
    Visser GD; Lill NL
    Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impaired degradation followed by enhanced recycling of epidermal growth factor receptor caused by hypo-phosphorylation of tyrosine 1045 in RBE cells.
    Gui A; Kobayashi A; Motoyama H; Kitazawa M; Takeoka M; Miyagawa S
    BMC Cancer; 2012 May; 12():179. PubMed ID: 22591401
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration.
    Zheng X; Chi J; Zhi J; Zhang H; Yue D; Zhao J; Li D; Li Y; Gao M; Guo J
    Oncogene; 2018 Jan; 37(4):502-511. PubMed ID: 28967900
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
    Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
    J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Silencing Aurora-kinase-A (AURKA) reinforced the sensitivity of diffuse large B-cell lymphoma cells to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) via suppressing β-Catenin and RAS-extracellular signal-regulated protein kinase (ERK1/2) pathway.
    Wang S; Sun L
    Bioengineered; 2021 Dec; 12(1):8296-8308. PubMed ID: 34565287
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Negative regulation of Lck by Cbl ubiquitin ligase.
    Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.
    Romo-Tena J; Rajme-López S; Aparicio-Vera L; Alcocer-Varela J; Gómez-Martín D
    Clin Exp Immunol; 2018 Jan; 191(1):42-49. PubMed ID: 28940360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.
    Chan W; Tian R; Lee YF; Sit ST; Lim L; Manser E
    J Biol Chem; 2009 Mar; 284(12):8185-94. PubMed ID: 19144635
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.
    Mohapatra B; Ahmad G; Nadeau S; Zutshi N; An W; Scheffe S; Dong L; Feng D; Goetz B; Arya P; Bailey TA; Palermo N; Borgstahl GE; Natarajan A; Raja SM; Naramura M; Band V; Band H
    Biochim Biophys Acta; 2013 Jan; 1833(1):122-39. PubMed ID: 23085373
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
    Sanada M; Suzuki T; Shih LY; Otsu M; Kato M; Yamazaki S; Tamura A; Honda H; Sakata-Yanagimoto M; Kumano K; Oda H; Yamagata T; Takita J; Gotoh N; Nakazaki K; Kawamata N; Onodera M; Nobuyoshi M; Hayashi Y; Harada H; Kurokawa M; Chiba S; Mori H; Ozawa K; Omine M; Hirai H; Nakauchi H; Koeffler HP; Ogawa S
    Nature; 2009 Aug; 460(7257):904-8. PubMed ID: 19620960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.
    Mazumdar A; Henderson YC; El-Naggar AK; Sen S; Clayman GL
    Head Neck; 2009 May; 31(5):625-34. PubMed ID: 19107951
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.
    Zhang Y; Sun L; Gao X; Guo A; Diao Y; Zhao Y
    BMC Cancer; 2019 Jul; 19(1):670. PubMed ID: 31286874
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.
    Katsha A; Wang L; Arras J; Omar OM; Ecsedy J; Belkhiri A; El-Rifai W
    Clin Cancer Res; 2017 Jul; 23(14):3756-3768. PubMed ID: 28073841
    [No Abstract]   [Full Text] [Related]  

  • 75. Spred-2 steady-state levels are regulated by phosphorylation and Cbl-mediated ubiquitination.
    Lock P; I ST; Straffon AF; Schieb H; Hovens CM; Stylli SS
    Biochem Biophys Res Commun; 2006 Dec; 351(4):1018-23. PubMed ID: 17094949
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Low expression of PTEN is essential for maintenance of a malignant state in human gastric adenocarcinoma via upregulation of p‑AURKA mediated by activation of AURKA.
    Li L; Song Y; Liu Q; Liu X; Wang R; Kang C; Zhang Q
    Int J Mol Med; 2018 Jun; 41(6):3629-3641. PubMed ID: 29512701
    [TBL] [Abstract][Full Text] [Related]  

  • 77. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.
    Guo H; Qiao G; Ying H; Li Z; Zhao Y; Liang Y; Yang L; Lipkowitz S; Penninger JM; Langdon WY; Zhang J
    Cell Rep; 2012 May; 1(5):472-82. PubMed ID: 22763434
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer.
    Lee YJ; Ho SR; Graves JD; Xiao Y; Huang S; Lin WC
    Breast Cancer Res; 2019 Dec; 21(1):134. PubMed ID: 31801577
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficient APC/C substrate degradation in cells undergoing mitotic exit depends on K11 ubiquitin linkages.
    Min M; Mevissen TE; De Luca M; Komander D; Lindon C
    Mol Biol Cell; 2015 Dec; 26(24):4325-32. PubMed ID: 26446837
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Knockout of c-Cbl slows EGFR endocytic trafficking and enhances EGFR signaling despite incompletely blocking receptor ubiquitylation.
    Crotchett BLM; Ceresa BP
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00756. PubMed ID: 33811466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.